PharmacyCodes



(2S,3S)-a-Amino-b-methyl-n-valeric acid en es it fr

(2S,3S)-a-Amino-b-methyl-n-valeric acid Brand names, (2S,3S)-a-Amino-b-methyl-n-valeric acid Analogs

(2S,3S)-a-Amino-b-methyl-n-valeric acid Brand Names Mixture

  • No information avaliable

(2S,3S)-a-Amino-b-methyl-n-valeric acid Chemical_Formula

C6H13N1O2

(2S,3S)-a-Amino-b-methyl-n-valeric acid RX_link

No information avaliable

(2S,3S)-a-Amino-b-methyl-n-valeric acid fda sheet

(2S,3S)-a-Amino-b-methyl-n-valeric acid msds (material safety sheet)

http://www.vinquiry.com/pdf/MSDS/L-Isoleucine MSDS.pdf

(2S,3S)-a-Amino-b-methyl-n-valeric acid Synthesis Reference

No information avaliable

(2S,3S)-a-Amino-b-methyl-n-valeric acid Molecular Weight

131.174 g/mol

(2S,3S)-a-Amino-b-methyl-n-valeric acid Melting Point

168-170 oC

(2S,3S)-a-Amino-b-methyl-n-valeric acid H2O Solubility

No information avaliable

(2S,3S)-a-Amino-b-methyl-n-valeric acid State

Solid

(2S,3S)-a-Amino-b-methyl-n-valeric acid LogP

-1.743

(2S,3S)-a-Amino-b-methyl-n-valeric acid Dosage Forms

Capsules, powder, tablets

(2S,3S)-a-Amino-b-methyl-n-valeric acid Indication

The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.

(2S,3S)-a-Amino-b-methyl-n-valeric acid Pharmacology

They provide ingredients for the manufacturing of other essential biochemical components in the body, some of which are utilized for the production of energy, stimulants to the upper brain and helping you to be more alert.

(2S,3S)-a-Amino-b-methyl-n-valeric acid Absorption

Absorbed from the small intestine by a sodium-dependent active-transport process

(2S,3S)-a-Amino-b-methyl-n-valeric acid side effects and Toxicity

Symptoms of hypoglycemia, increased mortality in ALS patients taking large doses of BCAAs

(2S,3S)-a-Amino-b-methyl-n-valeric acid Patient Information

No information avaliable

(2S,3S)-a-Amino-b-methyl-n-valeric acid Organisms Affected

Humans and other mammals